LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.
Frequently asked questions
What sector does LegoChem Biosciences Inc (141080) operate in?
LegoChem Biosciences Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is LegoChem Biosciences Inc (141080) current stock price?
As of the latest data, LegoChem Biosciences Inc stock price is ₩80,800, with a previous close of ₩80,800.
What is LegoChem Biosciences Inc (141080) current market capitalization?
LegoChem Biosciences Inc market cap is approximately 2.94 trillion.
Does LegoChem Biosciences Inc (141080) pay dividends?
No. LegoChem Biosciences Inc does not pay a dividend.
How did LegoChem Biosciences Inc (141080) perform in its most recent earnings report?
In the last report (June 30, 2026), LegoChem Biosciences Inc posted an EPS surprise of -180.35% and a revenue surprise of 65.69%.
What is LegoChem Biosciences Inc (141080) beta (volatility) score?
LegoChem Biosciences Inc has a beta of 0.485, indicating lower volatility than the overall market.
